Important Biotech Catalysts For September 13, 2022 – End Of The Day Summary
Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety…
Conformis Shares Shoot Higher Following FDA Clearance For Actera Hip System
Conformis (NASDAQ: CFMS) has received 510(k) clearance from the U.S. Food and Drug Administration for its Actera Hip System.
Actera utilizes an advanced tri-taper femur stem design that facilitates direct anterior approach total hip arthroplasties, and provides an additional stem option to orthopedic surgeons.
Conformis Actera Hip System Receives 510(k) Clearance From The U.S. FDA
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced that it has received 510(k) clearance from the U.S. Food and Drug
Conformis’s Return On Capital Employed Insights
According to data from Benzinga Pro, during Q2, Conformis's (NASDAQ:CFMS) reported sales totaled $15.29 million. Despite a 3.16% increase in earnings, the company posted a loss of $15.52 million.
Conformis Expects To Be At Low-End Of Operating Expenses Range Of $75M-$81M
Outlook
We expect our third quarter product revenue to be in the range of $13.0 million to $14.0 million.
We are updating our full year product revenue expectations to a range of $57
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Conformis Shares Jump On Personalized Orthopedic Implants Contract
Conformis Inc (NASDAQ:CFMS) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient’s membership of healthcare facilities. The…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.